Strategic funding Better Dairy has secured substantial venture funding (27M) signaling investor confidence and capacity to scale partnerships, making them a viable long-term collaborator for R&D and commercial supply agreements.

Breastmilk protein focus The company specializes in breastmilk protein innovation (starting with Osteopontin) using precision fermentation, presenting opportunities to partner on novel ingredient supply for infant nutrition, medical nutrition, and specialty dairy products.

Global dairy disruption Positioned to disrupt traditional dairy with science-driven alternatives, Better Dairy can target collaborations with infant formula producers, fortified beverage brands, and aging/health-focused dairy lines seeking smarter nutrition.

London-based R&D With a science and technology-led team centered in London, there are potential incentives for European co-development, joint innovation programs, and access to European regulatory and funding channels for biotech-enabled dairy ingredients.

Growing revenue potential Revenue range ($1M–$10M) and ongoing product development imply opportunity to engage in pilot supply agreements, contract manufacturing, and strategic equity or licensing discussions as they expand their full suite of breastmilk proteins and related components.